Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer
化疗开始时肿瘤标志物浓度比标志物半衰期更能预测治疗失败：一项针对播散性非精原细胞瘤睾丸癌患者的研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/bjc.1997.71
de Wit, R; Sylvester, R; Tsitsa, C; de Mulder, P H; Sleyfer, D T; ten Bokkel Huinink, W W; Kaye, S B; van Oosterom, A T; Boven, E; Vermeylen, K; Stoter, G
